TrialHaematologica2017

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study.

Vincent Ribrag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.